City of Hope is first in world to test oncolytic virus, CF33-hNIS, in people with metastatic solid tumours
Blenrep combinations could redefine treatment as early as first relapse where more effective options are needed
Late-stage Fabhalta development program ongoing in multiple complement-mediated conditions
Phase 2 clinical trial to begin in 2022 with participation by Cedars Sinai Medical Center, University of Utah, and City of Hope
Subscribe To Our Newsletter & Stay Updated
